Intellectual Property India Publishes Patent Application for 'Genetically Modified Host Cells Producing L-Serine' Filed by Cysbio Aps

MUMBAI, India, May 30 -- Intellectual Property India has published a patent application (202517042770 A) filed by Cysbio Aps, Horsholm, Denmark, on May 2, for 'genetically modified host cells producing l-serine.'

Inventor(s) include Mundhada, Hemanshu; Escher, Belinda; Chandrasekaran, Priyadharshini; Nielsen, Alex Toftgaard; Popinceanu, Adina-Roxana; and Ortega, Esther, Prosper.

The application for the patent was published on May 30, under issue no. 22/2025.

According to the abstract released by the Intellectual Property India: "The present invention relates to a genetically engineered host cell producing a metabolite from 3- phosphoglycerate through a metabolic pathway, comprising one or more genetic modifications preventing or reducing or alleviating a negative impact on production of the metabolite from intracellular accumulation of NADH and/or hydroxy glutarate (HGA), produced by one or more pathway enzymes."

The patent application was internationally filed on Oct. 20, 2023, under International application No.PCT/EP2023/079297.

Disclaimer: Curated by HT Syndication.